UC Berkeley drops plans to release personal genetic information to incoming freshmen
By Lisa Krieger,
San Jose Mercury News
| 08. 12. 2010
[Quotes CGS's Jesse Reynolds]
The University of California Berkeley has dropped plans to release personal genetic information to incoming freshmen, following instruction by state officials.
The educational program, called "Bring Your Genes to Cal," came under fire by the California Department of Public Health because of state rules prohibiting gene testing outside a medical setting.
Health officials ruled Wednesday that the university could not proceed because it failed to obtain a physician's order for each student and process samples at a state-approved lab for analysis. The laws are designed to assure accuracy and quality of medical tests.
About 700 of the 5,500 incoming students have already sent in samples, on a voluntary and anonymous basis, to participate in what was intended to be a way to teach students about the growing role of genetics in daily life. In addition to the tests, it planned to provide lectures and discussions with ethicists, statisticians, biologists and philosophers about gene testing.
At a Thursday news conference, UC Berkeley professor of genetics Jasper Rine said that while the university still plans to analyze the DNA samples in a...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
